Market Research Logo

Microbiotix, Inc. - Product Pipeline Review - 2016

Microbiotix, Inc. - Product Pipeline Review - 2016

Summary



Global Markets Direct’s, ‘Microbiotix, Inc. - Product Pipeline Review - 2016’, provides an overview of the Microbiotix, Inc.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Microbiotix, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Microbiotix, Inc.
  • The report provides overview of Microbiotix, Inc. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Microbiotix, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Microbiotix, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate Microbiotix, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Microbiotix, Inc.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Microbiotix, Inc.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


Microbiotix, Inc. Snapshot
Microbiotix, Inc. Overview
Key Information
Key Facts
Microbiotix, Inc. - Research and Development Overview
Key Therapeutic Areas
Microbiotix, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Microbiotix, Inc. - Pipeline Products Glance
Microbiotix, Inc. - Clinical Stage Pipeline Products
Phase I Products/Combination Treatment Modalities
Microbiotix, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Microbiotix, Inc. - Drug Profiles
filociclovir
Product Description
Mechanism of Action
R&D Progress
MBX-700
Product Description
Mechanism of Action
R&D Progress
MBX-500
Product Description
Mechanism of Action
R&D Progress
MBX-701
Product Description
Mechanism of Action
R&D Progress
MBX-900
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit 16S rRNA for Tuberculosis
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit T3SS for Pseudomonas Aeruginosa Infections
Product Description
Mechanism of Action
R&D Progress
KKL-35
Product Description
Mechanism of Action
R&D Progress
MBX-2168
Product Description
Mechanism of Action
R&D Progress
MBX-2319
Product Description
Mechanism of Action
R&D Progress
MBX-2329
Product Description
Mechanism of Action
R&D Progress
MBX-2359
Product Description
Mechanism of Action
R&D Progress
MBX-2402
Product Description
Mechanism of Action
R&D Progress
MBX-2546
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit DNA Helicase for Infectious Diseases
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Ebola Virus Infection
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Fungal Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Gram-Negative Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Anthrax Lethal Factor Toxin for Anthrax
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit bNOS for MRSA Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit BoNT/A LC for Botulism
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit DNA Synthesis for Gram-Negative and Gram-Positive Bacterial Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit NPC1 for Filovirus Infections
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit PSAC for Malaria
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit the Fatty Acid Synthesis II for Pseudomonas Aeruginosa Infections
Product Description
Mechanism of Action
R&D Progress
Microbiotix, Inc. - Pipeline Analysis
Microbiotix, Inc. - Pipeline Products by Target
Microbiotix, Inc. - Pipeline Products by Route of Administration
Microbiotix, Inc. - Pipeline Products by Molecule Type
Microbiotix, Inc. - Pipeline Products by Mechanism of Action
Microbiotix, Inc. - Dormant Projects
Microbiotix, Inc. - Locations And Subsidiaries
Head Office
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Microbiotix, Inc., Key Information
Microbiotix, Inc., Key Facts
Microbiotix, Inc. - Pipeline by Indication, 2016
Microbiotix, Inc. - Pipeline by Stage of Development, 2016
Microbiotix, Inc. - Monotherapy Products in Pipeline, 2016
Microbiotix, Inc. - Phase I, 2016
Microbiotix, Inc. - Preclinical, 2016
Microbiotix, Inc. - Discovery, 2016
Microbiotix, Inc. - Pipeline by Target, 2016
Microbiotix, Inc. - Pipeline by Route of Administration, 2016
Microbiotix, Inc. - Pipeline by Molecule Type, 2016
Microbiotix, Inc. - Pipeline Products by Mechanism of Action, 2016
Microbiotix, Inc. - Dormant Developmental Projects,2016
List of Figures
Microbiotix, Inc. - Pipeline by Top 10 Indication, 2016
Microbiotix, Inc. - Pipeline by Stage of Development, 2016
Microbiotix, Inc. - Monotherapy Products in Pipeline, 2016
Microbiotix, Inc. - Pipeline by Top 10 Target, 2016
Microbiotix, Inc. - Pipeline by Route of Administration, 2016
Microbiotix, Inc. - Pipeline by Molecule Type, 2016
Microbiotix, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report